Delivery Order SPE2DB24D1007-SPE2DB25FCCNU
- Not listed
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a $6,148.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract is non-set-aside and competitively awarded, with performance taking place at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,205.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $19,662.17 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,768.42 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This firm fixed price contract, which is not set-aside and is scheduled for completion by July 28, 2025, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. The delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $25,617.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 23, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,135.04 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,525.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on July 22, 2025, with completion targeted for July 23, 2025. This non-set-aside competitively awarded contract represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $15,184.50 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was issued without set-aside designation, reflecting open competition among qualified vendors. This...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCNUDelivery Order
The Defense Logistics Agency awarded a $5,160.18 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company has an extensive portfolio of delivery orders with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. All of AmerisourceBergen's reviewed contract awards have been competitively awarded non-set-aside contracts with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements through open competition and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/21/25 |